PREEMIE PROBLEM Giving the steroid dexamethasone to premature babies helps free them early from a ventilator but increases their risk of infection and can slow their growth.
Bristol-Myers Squibb and AbbVie Announce Progression-Free Survival Data from Phase 2 Open-Label Study of ... Bristol-Myers Squibb Company and AbbVie today announced updated efficacy and safety data from a small, randomized Phase 2, open-label study in patients with previously-treated multiple myeloma that evaluated two doses of the investigational monoclonal antibody elotuzumab in combination with lenalidomide and low-dose dexamethasone.
June 15, 2013 - Business Wire via Yahoo! Finance
Dr Rajkumar in Genetic Engineering News (press release) The lower survival rates with the high dose dexamethasone can be attributed to disease progression as well as treatment-related toxicities,said S. Vincent Rajkumar, MD, Mayo Clinic Cancer Center hematologist and lead investigator of the...